SAEED HASHEMI: Open Payments
NPI 1831108612 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$669 in 37 payments from 7 companies in 2025. Trend: 2023 $211 · 2024 $348 · 2025 $669
Food & beverage: $570Education: $99
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 21 | $293 |
| Janssen Biotech, Inc. | 4 | $141 |
| Phathom Pharmaceuticals, Inc. | 5 | $79 |
| ABBVIE INC. | 3 | $65 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| Ipsen Biopharmaceuticals, Inc | 1 | $30 |
| Madrigal Pharmaceuticals | 1 | $25 |
Products named: IBSRELA, TREMFYA, VOQUEZNA, XIFAXAN, IQIRVO, RINVOQ, REZDIFFRA, VIBERZI.
Industry payments across CA — which companies pay providers there.
